Verdict Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Most Read

  1. Q&A: talking clinical trial tech and acquisitions with Medidata
  2. Oxford VR secures $12.5m investment for VR therapy tech
  3. New analysis raises concerns over accuracy of skin cancer risk apps
  4. Bone marrow chip opens research options for Shwachman-Diamond syndrome
  5. DiviTum validated as early evaluation tech for metastatic breast cancer

Company A-Z

Latest Content

Medicare Taiwan Expo 2020

The 2020 MEDICARE TAIWAN (Taiwan International Medical & Healthcare Exhibition) tradeshow creates an international platform that focuses on medical devices, hospital equipment and healthcare solutions in Taiwan.

Q&A: talking clinical trial tech and acquisitions with Medidata

Medidata's clinical trial tech is used in approximately half of all life science research products around the world. Now, the company has been acquired by Dassault Systèmes, in a merger that could be transformative for the medtech and pharma industries. Chloe Kent speaks to three of Medidata’s key players to find out more.

Reliable Cervical Cancer Screening

Based on available study data, GynTect® provides a clear indication of malignancy status in patients with abnormal Pap smear: In all previous studies, GynTect® was able to detect all cancer cases of the cervix (Sensitivity = 100%).

Latest News

Read our magazine

Medical Technology is the essential reading material for decision-makers in the medical device industry, bringing you the latest news and analysis in an exciting, interactive format.

Send me notifications of new editions:

Close
Close
Close

Driving towards the implementation of the new Medical Devices Regulations (MDR)

  On 5 April 2017, two new Medical Devices Regulations (MDR) on medical devices were adopted, and they entered into…
Read More…

Close

Go Top